Search alternatives:
mm decrease » nn decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
ng decrease » nn decrease (Expand Search), we decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decreased (Expand Search), _ decreases (Expand Search)
12 mm » 10 mm (Expand Search), 2 mm (Expand Search), 15 mm (Expand Search)
5 ng » 5 mg (Expand Search), 5 g (Expand Search), 5 nm (Expand Search)
mm decrease » nn decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
ng decrease » nn decrease (Expand Search), we decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decreased (Expand Search), _ decreases (Expand Search)
12 mm » 10 mm (Expand Search), 2 mm (Expand Search), 15 mm (Expand Search)
5 ng » 5 mg (Expand Search), 5 g (Expand Search), 5 nm (Expand Search)
-
1
HRMECs treated with SUZ12 siRNA demonstrate increased miR-200b expression, decreased VEGF expression and decreased endothelial branching.
Published 2015“…[NG+control siRNA = 5mM D-glucose + 100nM control siRNA, HG+control siRNA = 25mM D-glucose + 100nM control siRNA, HG+EZH2 siRNA = 25mM D-glucose + 100nM EZH2 siRNA, HG+SUZ12 siRNA = 25mM + 100nM SUZ12 siRNA; identical letters represent groups that are not significantly different; p < 0.05; n = 6; data expressed as mean ± SEM, normalized to U6 or β-actin and expressed as a fold change of NG+control siRNA].…”
-
2
TQ decreases CXCR4 expression on MM cells and CXCL12-induced CXCR4/CD45 association.
Published 2011Subjects: -
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
MK-STYX decreases RhoA activation.
Published 2014“…<p>(<b>A</b>) PC12 cells were transfected with pMT2 or pMT2-FLAG-MK-STYX-FLAG. 24 hr post-transfection cells were stimulated with 100 ng/ml NGF, and lysed at the indicated time points. …”
-
11
-
12
-
13
-
14
-
15
-
16
-
17
-
18
-
19
TGF-β-mediated EMT decreases Dlg5 expression.
Published 2012“…The scale bar indicates 10 µm. TGF-β treatment induced EMT and decreased Dlg5 expression. …”
-
20
Inhibition of the <i>Hedgehog</i> pathway leads to decreased ostegenesis <i>in vitro</i>.
Published 2013“…<p>(A–B) qRT-PCR of e13.5 wild-type, CD-1 palate cultures treated with DMEM F12 +/− supplementation with cyclopamine (20 mM) or Shh-N (250 ng/mL) for 2 days. …”